FDA's Push for Safer Cancer Drugs Sparks Startup Concerns! 💊

News & Articles
1

Summary:

  1. New Dosing Guidelines
    The FDA’s Project Optimus calls for re-evaluating cancer drug doses to reduce side effects, requiring drugmakers to test lower doses for better safety and efficacy.

  2. Impact on Trials
    The initiative may lead to larger and longer clinical trials, which some startups worry could increase costs and extend development times, putting them at a disadvantage.

  3. Regulatory Balance
    While the FDA aims to improve patient safety, it reassures that it will work with drugmakers to expedite the approval process for new treatments.

Read more at: WSJ

1 Like